|
Daily Medical Update
Systemic inflammatory response syndrome and septic shock
Tuesday, August 11, 2026
|
🔬 Practice-Changing Findings
Evidence from RCTs and meta-analyses published in the
last 12 months.
|
Pediatric critical care medicine (2026) - Practice Guideline and Systematic Review
Key Findings
- The panel issued 61 management statements, including 5 strong, 24 conditional, and 10 good-practice statements, improving the clinical management framework relative to 2020.
- Only 3 of 61 management statements were supported by high or moderate-certainty evidence, leaving mortality and other clinical effects uncertain for most recommendations.
📋 Practice Implication: Pediatric sepsis protocols should be updated to the 2026 framework, with local teams clearly labeling which recommendations are conditional or supported by low-certainty evidence.
|
Critical care explorations (2025) - Systematic Review and Meta-Analysis
Key Findings
- Dynamic-guided fluid administration probably reduced 28-day mortality in septic shock (RR 0.61, 95% CI 0.42-0.90).
- The approach may reduce acute kidney injury (RR 0.66, 95% CI 0.44-0.98) and day-3 cumulative fluid balance by 1.57 L (95% CI -2.44 to -0.69 L).
📋 Practice Implication: In adult septic shock, use dynamic fluid-responsiveness assessments to individualize boluses and reduce avoidable fluid accumulation while supporting perfusion.
|
The American journal of emergency medicine (2025) - Network Meta-Analysis
Key Findings
- Balanced crystalloids were favored over low-molecular-weight hydroxyethyl starch and saline for reducing 90-day mortality across 28 randomized trials involving 8,770 patients.
- Balanced crystalloids ranked highest for 28-day mortality (SUCRA 71.4%), renal-replacement-therapy demand (75.5%), blood transfusion (72.2%), and 90-day mortality (86.3%); hyperoncotic albumin ranked highest for reducing acute kidney injury (74.5%).
📋 Practice Implication: Balanced crystalloids are the best-supported default crystalloid for sepsis resuscitation, while albumin selection should remain individualized when renal outcomes are a priority.
|
Intensive & critical care nursing (2025) - Systematic Review and Meta-Analysis
Key Findings
- Short-term mortality was 20.8% with the 1-hour bundle versus 24.7% with the non-1-hour bundle, with a pooled mortality effect estimate corresponding to a 95% CI of 0.69-0.84.
- The mortality benefit was more pronounced in ICU and prospective studies, but was not statistically clear in emergency-department or retrospective studies.
📋 Practice Implication: Hospitals should strengthen rapid sepsis recognition and bundle-completion workflows in critical care, while treating emergency-department mortality benefit as uncertain until stronger trials are available.
|
BMC anesthesiology (2025) - Meta-Analysis of 18 RCTs
Key Findings
- Across 18 randomized trials involving 7,982 patients, corticosteroid therapy reduced 28-day mortality (RR 0.88, 95% CI 0.79-0.98); mortality was 31.0% versus 35.5% with control treatment.
- The strongest dose-stratified result occurred with 201-300 mg/day hydrocortisone-equivalent regimens (risk ratio 0.86), while hydrocortisone plus fludrocortisone was associated with risk ratio 0.89; effects were weaker in trials conducted in China.
📋 Practice Implication: When corticosteroids are indicated for adult septic shock, moderate-dose regimens and a fludrocortisone adjunct merit protocol-level consideration, with attention to dose and regional heterogeneity.
|
|
💡
Summary
Five high-significance studies update pediatric sepsis guidance, fluid-resuscitation selection and monitoring, early bundle implementation, and corticosteroid use. The evidence favors dynamic fluid-responsiveness assessment, balanced crystalloids, timely ICU bundle delivery, and moderate-dose corticosteroid strategies, while emphasizing that certainty remains limited for much pediatric guidance and for emergency-department bundle effects.
|
|